drugset

drugset / Trial / NCT06346925

Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects.

NCT06346925 ↗

Phase 1 Unknown 18 enrolled Jiangsu HengRui Medicine Co., Ltd.

RandomizedCrossoverOpen-labelTreatment

Summary

This study was designed as a single-center, randomized, open, two-cycle, cross-over trial. It is planned to enroll 18 healthy subjects

Timeline

Start: 2024-04
Primary completion: 2024-07
Completion: 2024-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	RAFUTROMBOPAG	Other / unclassified	7.5 mg	—

Indications